Viewing Study NCT05897294

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-01-07 @ 11:17 AM
Study NCT ID: NCT05897294
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-11-21
First Post: 2023-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
Sponsor: TFF Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Invasive Pulmonary Aspergillosis View
None Allergic Bronchopulmonary Aspergillosis View
None Chronic Pulmonary Aspergillosis View
None Aspergillus Tracheobronchitis View
None Anastomotic Infection View
None Pulmonary Fungal Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None voriconazole View
None Pulmonary Aspergillosis View